Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Van Neste, Leander" or (type any "bookEditor issueEditor" and editor="Van Neste, Leander")

Add to list
- Journal Article
- A1
- open access
Evaluation of an epigenetic assay for predicting repeat prostate biopsy outcome in African American men

Robert L, Jr Waterhouse, Leander Van Neste, Kelvin A Moses, Carlton Barnswell, Jonathan L Silberstein, Mark Jalkut, Ronald Tutrone, James Sylora, Ronald Anglade, Myron Murdock, et al.

(2019) UROLOGY. 128. p.62-65
Add to list
Analysis of DNA methylation in cancer : location revisited

Alexander Koch, Sophie C Joosten, Zheng Feng, Tim C de Ruijter, Muriel X Draht, Veerle Melotte, Kim M Smits, Jurgen Veeck, James G Herman, Leander Van Neste, et al.

(2018) NATURE REVIEWS CLINICAL ONCOLOGY. 15(7). p.459-466
Add to list
Cost-effectiveness of a new urinary biomarker-based risk score compared to standard of care in prostate cancer diagnostics : a decision analytical model

Siebren Dijkstra, Tim M Govers, Rianne J Hendriks, Jack A Schalken, Wim Van Criekinge (UGent) , Leander Van Neste, Janneke PC Grutters, John P Michiel Sedelaar and Inge M van Oort

(2017) BJU INTERNATIONAL. 120(5). p.659-665
Add to list
Epigenetic risk score improves prostate cancer risk assessment

Leander Van Neste, Jack Groskopf, William E Grizzle, George W Adams, Mark S DeGuenther, Peter N Kolettis, James E Bryant, Gary P Kearney, Michael C Kearney, Wim Van Criekinge (UGent) , et al.

(2017) PROSTATE. 77(12). p.1259-1264
Add to list
- Conference Paper
- C3
Clinical performance of an epigenetic assay to identify occult high-grade prostate cancer in African American men

Leander Van Neste, Carlton Barnswell, Mark Jalkut, Ronald Tutrone, James Sylora, Ronald Anglade, Myron Murdock, Kelvin A Moses, Zvi Shiffman, Todd Vandenberg, et al.

(2017) JOURNAL OF UROLOGY. 197(4, suppl.). p.E128-E128

Academic Bibliography

Evaluation of an epigenetic assay for predicting repeat prostate biopsy outcome in African American men

Analysis of DNA methylation in cancer : location revisited

Cost-effectiveness of a new urinary biomarker-based risk score compared to standard of care in prostate cancer diagnostics : a decision analytical model

Epigenetic risk score improves prostate cancer risk assessment

Clinical performance of an epigenetic assay to identify occult high-grade prostate cancer in African American men

Contents

Support

Contact